RenovaCare
About RenovaCare
RenovaCare, Inc., formerly Janus Resources, Inc., is a biotechnology company. The Company is focused on the acquisition, research, development and commercialization of autologous cellular therapies that can be used for medical and aesthetic applications. The Company's initial products under development target skin. The Company, through RenovaCare Sciences Corp., offers treatment methodology for cell isolation for the regeneration of human skin cells, along with a medical-grade liquid spraying device and associated equipment (the SkinGun). It is evaluating the efficacy and potential of SkinGun, in combination with a cell isolation method, in the treatment of tissue that has been subject to severe trauma.
Company Metrics
- Employees: 1-10
- Monthly Visits: None
- Tech Stack: 20 active products
Financial Information
- Estimated Revenue: Less than $1M
- Total Funding: 17800000 USD
- Last Funding: 15500000 USD (Post-IPO Equity)
- Funding Status: IPO
Technology Stack
RenovaCare actively uses 20 products in their tech stack.
Market Presence
Industries: Biotechnology, Medical Device, Therapeutics
Headquarters: New York, New York, United States